Table 1.
Patient Demographic and Clinical Data.
| Factor | Patients (n = 20) |
|---|---|
| Women, % | 100 |
| Age, mean (SD, range), years | 53.2 (10.9, 36–76) |
| BMI, mean (SD, range), kg/m2 | 35.3 (8.1, 25–52.5) |
| Ethnicity, n (%) | |
| Hispanic or Latino | 8 (40%) |
| White | 8 (40%) |
| African American | 4 (20%) |
| Past medical history, n (%) | |
| Chronic rhinosinusitis | 7 (35%) |
| Hypertension | 10 (50%) |
| Diabetes | 4 (20%) |
| Seizure disorder | 3 (15%) |
| Neurocysticercosis | 1 (5%) |
| Past surgical history, n (%) | |
| Lateral skull base CSF leak | 1 (5%) |
| Sinus surgery | 0 (0%) |
| Acetazolamide | 6 (30%) |
| Tobacco use | 5 (25%) |
| Time symptomatic, mean (range), months | 6.6 (1–18) |
| Presenting symptoms, n (%) | |
| Clear rhinorrhea | 20 (100%) |
| Headache | 10 (50%) |
| Meningitis | 3 (15%) |
| Pneumonitis | 4 (20%) |
| Seizure | 1 (5%) |
| Empty sella syndrome on MRI | 9 (45%) |
| Postoperative admission, mean (range), days | 7 (4–10) |
| Postoperative use of acetazolamide, n (%) | 5 (25%) |
| Clinic follow-up, mean (range), months | 22.8 (3–66) |
Abbreviations: BMI, body mass index; CSF, cerebrospinal fluid; MRI, magnetic resonance imaging; SD, standard deviation.